| ［1］ Steele MW, Breg WR Jr. Chromosome analysis of human amniotic-fluid cells［J］. Lancet, 1966, 1: 383-385.［2］ Bianchi DW. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges［J］. Nat Med, 2012, 18(7): 1041-1051.［3］ Done E, Gucciardo L, Van Mieghem T, et al. Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia［J］. Prenat Diagn, 2008, 28:581-591.［4］ Morris RK, Kilby MD. Long-term renal and neurodevelopmental outcome in infants with LUTO, with and without fetal intervention［J］. Early Hum Dev, 2011, 87:607-610.［5］ Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele［J］. N Engl J Med, 2011, 364:993-1004.［6］ Yun-Chi Tang, Amon A. Gene Copy-Number Alterations: A Cost-Benefit Analysis［J］. Cell, 2013, 152:394-405.［7］ Redon R, Ishikawa S, Fitch KR,et al. Global variation in copy number in the human genome［J］. Nature, 2006, 444(7118):444-454.［8］ The American College of Obstetricians and Gynecologists Committee on Genetics Society for Maternal-Fetal Medicine, Committee Opinion No. 581 (replaces No. 446 in 2009, 11), the Use of Chromosomal Microarray Analysis in Prenatal Diagnosis, 2013;12［9］ South ST, Lee C, Lamb AN, et al. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013［J］. Genet Med, 2013, 15(11):901-909.［10］ Hillman SC, Mcmullan DJ,Williams D, et al. Microarray comparative genomic hybridization in prenatal diagnosis: a review［J］. Ultrasound Obstet Gynecol, 2012, 40: 385-391.［11］ Schaaf CP, Wiszniewska J, Beaudet AL. Copy number and SNP arrays in clinical diagnostics［J］. Annu Rev Genomics Hum Genet,2011, 12:25-51.［12］ Donnelly J, Platt L, Rebarber A, et al. Association of Copy Number Variants With Single and Multiple Structural Anomalies of Specific Fetal Organ Systems Presented at 17th International Conference on Prenatal Diagnosis and Therapy, 2013, Lisbon Portugal.［13］ Reddy UM,Page GP, Saade GR, et al. Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth［J］. N Engl J Med, 2012, 367:2185-2193.［14］ Breman A, Pursley AN, Hixson P, et al. Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature［J］. Prenatal Diagnosis, 2012, 32: 351-361.［15］ Lee CN, Lin SY, Lin CH, et al. Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies［J］. BJOG, 2012, 119:614-625.［16］ Wapner RJ, Martin CL, Levy B, et al. Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis［J］. NEJM, 2012, 367(23):2175-2185.［17］ Kearney HM, South ST, Wolff DJ, et al. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities［J］. Genet Med, 2011, 13:676-679.［18］ Shaffer LG, Dabell MP, Rosenfeld JA, et al. Referral patterns for microarray testing in prenatal diagnosis［J］. Prenatal Diagnosis, 2012, 32: 344-350.［19］ Dewit MC,Srebniak MI,Govaerts LCP, et al. Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature［J］. Ultrasound Obstet Gynecol, 2014, 43: 139-146.（2014-06-08收稿 2014-06-13修回） |
